Most people with long duration of type 1 diabetes are insulin microsecretors and produce their own endogenous insulin

被引：0
|
作者：
McDonald, T. J. [1 ]
Oram, R. [1 ]
Shields, B. [1 ]
Pearson, E. [2 ]
Hattersley, A. [1 ]
机构：
[1] Univ Exeter, Sch Med, Exeter EX4 4QJ, Devon, England
[2] Univ Dundee, Med Res Inst, Dundee DD1 4HN, Scotland
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
510
引用
收藏
页码：S213 / S213
页数：1
相关论文
共 50 条
  • [1] A large, population-based study demonstrates that most people with long duration Type 1 diabetes are insulin microsecretors and produce their own endogenous insulin
    Oram, R. A.
    McDonald, T. J.
    Shields, B. M.
    Pearson, E. R.
    Hattersley, A. T.
    [J]. DIABETIC MEDICINE, 2014, 31 : 10 - 10
  • [2] Most People With Long-Duration Type 1 Diabetes in a Large Population-Based Study Are Insulin Microsecretors
    Oram, Richard A.
    McDonald, Timothy J.
    Shields, Beverley M.
    Hudson, Michelle M.
    Shepherd, Maggie H.
    Hammersley, Suzanne
    Pearson, Ewan R.
    Hattersley, Andrew T.
    [J]. DIABETES CARE, 2015, 38 (02) : 323 - 328
  • [3] The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
    Richard A. Oram
    Angus G. Jones
    Rachel E. J. Besser
    Bridget A. Knight
    Beverley M. Shields
    Richard J. Brown
    Andrew T. Hattersley
    Timothy J. McDonald
    [J]. Diabetologia, 2014, 57 : 187 - 191
  • [4] The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
    Oram, Richard A.
    Jones, Angus G.
    Besser, Rachel E. J.
    Knight, Bridget A.
    Shields, Beverley M.
    Brown, Richard J.
    Hattersley, Andrew T.
    McDonald, Timothy J.
    [J]. DIABETOLOGIA, 2014, 57 (01) : 187 - 191
  • [5] Erratum to: The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
    Richard A. Oram
    Angus G. Jones
    Rachel E. J. Besser
    Bridget A. Knight
    Beverley M. Shields
    Richard J. Brown
    Andrew T. Hattersley
    Timothy J. McDonald
    [J]. Diabetologia, 2014, 57 (1) : 262 - 262
  • [6] INSULIN RESISTANCE IN TYPE-1 DIABETES OF LONG DURATION
    SINGH, BM
    NATTRASS, M
    [J]. CLINICAL SCIENCE, 1986, 70 : P19 - P19
  • [7] Insulin degludec: The new standard long acting insulin analogue for people with type 1 diabetes?
    Angel Merchante-Alfaro, Agustin
    Perez-Naranjo, Susana
    Abellan-Galiana, Pablo
    Rubio-Puchol, Olalla
    [J]. ENDOCRINE JOURNAL, 2016, 63 (04) : 411 - 412
  • [8] Delayed Insulin Secretory Responses Are Seen in Patients with Long Duration of Type 1 Diabetes and Residual Insulin
    Sherr, Jennifer
    Rink, Linda
    Herold, Kevan
    [J]. DIABETES, 2011, 60 : A446 - A446
  • [9] Insulin Administration for People with Type 1 diabetes
    Boiroux, Dimitri
    Finan, Daniel Aaron
    Poulsen, Niels Kjolstad
    Madsen, Henrik
    Jorgensen, John Bagterp
    [J]. 21ST EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, 2011, 29 : 1558 - 1562
  • [10] The Impact of Diabetes Duration on Safety and Effectiveness of Insulin Analogs in Insulin-Naive People with Type 2 Diabetes
    Home, Philip
    Khattab, Mohammed
    Swaraj, Soji
    Feriz, Karen
    Prusty, Vinay
    Ghannam, Nadia
    [J]. DIABETES, 2014, 63 : A226 - A226
12345